On September 12, Abby Joseph Cohen, Columbia Business School professor and former Goldman Sachs partner & chief US strategist, joined ‘Squawk Box’ on CNBC to discuss the latest market trends, state of the economy, impact of tariffs, and suggested that she’s a long-term bull on the US. Cohen believes that the US economy is by far the most impressive in the world, but always watches for risks. She explained that while the market typically trades in the center of a bell curve, the real opportunities and risks lie at the extreme ends. One long-term risk Cohen is currently monitoring is the relationship between the US and China. Specifically, she is worried about the apparent lack of US investment in science, tech, and education compared to China. Cohen also reiterated her view on whether stocks are overpriced and stated that they are fully priced, particularly the market-cap-weighted indices.
On September 17, Shashwat Chauhan and Johann M Cherian of Reuters reported that the US corporate sectors sensitive to interest rates are drawing focus as the Fed prepares for its first expected rate cut of 2025. The US stock markets are currently at record highs, with tech and bank stocks among the top performers this year. Small-cap companies benefit from lower rates. The outlook for banks is more complex as they typically profit more when rates rise, and competition for deposits can increase funding costs. Growth stocks, including major tech companies like MAG7, benefit from rate cuts as lower rates increase the present value of their future expected profits.
That being said, we’re here with a list of the 12 most promising long-term stocks to buy.
Methodology
We first sifted through the Finviz stock screener and financial media reports to compile a list of the top stocks with a 5-year revenue compound annual growth rate of over 20%. We then selected the 12 stocks that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q2 2025.
Note: All data was sourced on September 19.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
12 Most Promising Long-Term Stocks to Buy
12. Exact Sciences Corporation (NASDAQ:EXAS)
5-Year Revenue CAGR: 21.05%
Number of Hedge Fund Holders: 50
Exact Sciences Corporation (NASDAQ:EXAS) is one of the most promising long-term stocks to buy. On September 17, Exact Sciences formed a partnership with Healthmine, which is a member engagement and rewards platform for health plans, to boost colorectal cancer/CRC screening completion rates. The collaboration focuses on integrating Exact Sciences’ Cologuard at-home testing with health plan incentives provided through Healthmine’s platform.
The initiative is designed to close critical preventive care gaps and promote the early detection of colorectal cancer, which is a key focus area for both the NCQA’s HEDIS measures and CMS’s renewed emphasis on prevention and wellness across Medicare and Medicaid.
Members of participating health plans will receive rewards for completing and returning the noninvasive Cologuard stool DNA screening test. This incentive-driven approach is supported by Healthmine’s behavioral science-driven communications and is already proven to be effective: Healthmine’s health plan partners typically see a 25% completion improvement over baseline in CRC screening measure programs, a 52% improvement in overall gap closure across all programs, and an average 93% increase in gap closure among members in rewards programs.
Exact Sciences Corporation (NASDAQ:EXAS) provides cancer screening and diagnostic test products in the US and internationally.
11. Celsius Holdings Inc. (NASDAQ:CELH)
5-Year Revenue CAGR: 74.58%
Number of Hedge Fund Holders: 52
Celsius Holdings Inc. (NASDAQ:CELH) is one of the most promising long-term stocks to buy. On September 8, Celsius Holdings announced that it appointed Rishi Daing as its new Chief Marketing Officer, effective the same day. The appointment is part of a broader move to strengthen the company’s marketing capabilities and advance its portfolio growth strategy, which includes brands like CELSIUS, AlaniNu, and RockstarEnergy.
Daing brings over two decades of global marketing and commercial leadership experience to the role. His background includes senior positions at PepsiCo and Tata Consumer Products, and most recently, at Mark Anthony Brands, where he led the launch of Mas+ with Lionel Messi. As CMO, Daing will be overseeing the marketing strategy across the entire Celsius Holdings portfolio, working to unify brand development, go-to-market execution, and digital platforms under a performance-driven framework.
He will report to President and Chief Operating Officer Eric Hanson and be based at the company’s U.S. headquarters in Boca Raton, Florida. In addition to the CMO appointment, Celsius Holdings also announced the creation of a new Marketing Leadership Team and promotions to fill the new Chief Brand Officer and Chief Creative Officer roles.
Celsius Holdings Inc. (NASDAQ:CELH) develops, processes, manufactures, markets, sells, and distributes functional energy drinks in North America, Europe, the Asia Pacific, and internationally.
Hedge Fund Resource Center